LEANNE GRIFFIN: Open Payments
NPI 1265635981 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 99 payments from 21 companies in 2025. Trend: 2023 $1,827 · 2024 $1,569 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $415 |
| ABBVIE INC. | 22 | $356 |
| Amgen Inc. | 11 | $189 |
| PFIZER INC. | 12 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $140 |
| Lilly USA, LLC | 6 | $100 |
| Novo Nordisk Inc | 4 | $70 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Eisai Inc. | 2 | $40 |
Products named: AIRSUPRA, QULIPTA, NURTEC ODT, CAPLYTA, VRAYLAR, OTEZLA, FARXIGA, BREZTRI.
Industry payments across AR — which companies pay providers there.
